MeSH term
Frequency | Condition_Probility | Animals | 14 | 0.0 |
DNA, Mitochondrial/*genetics | 2 | 1.0 |
Disease Models, Animal | 2 | 0.0 |
Humans | 53 | 0.0 |
Mutation | 5 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 19 | 0.0 |
Cell Division | 2 | 0.0 |
Cell Line | 6 | 0.0 |
Rats | 2 | 0.0 |
Recombinant Proteins/metabolism | 2 | 0.0 |
Transfection | 7 | 0.0 |
Glutathione Peroxidase/metabolism | 3 | 8.0 |
Iodide Peroxidase/metabolism | 2 | 16.0 |
Thioredoxin Reductase (NADPH)/metabolism | 2 | 18.0 |
Mice | 6 | 0.0 |
Models, Biological | 3 | 0.0 |
Amino Acid Substitution | 2 | 0.0 |
DNA Primers | 4 | 0.0 |
Female | 15 | 0.0 |
Genetic Predisposition to Disease | 3 | 0.0 |
Glutathione Peroxidase/*genetics | 13 | 56.0 |
Male | 17 | 0.0 |
Polymerase Chain Reaction | 6 | 0.0 |
Research Support, Non-U.S. Gov't | 34 | 0.0 |
Glutathione Transferase/*genetics | 2 | 0.0 |
Phenotype | 6 | 0.0 |
*Polymorphism, Genetic | 8 | 0.0 |
Glutathione Peroxidase/*biosynthesis | 3 | 100.0 |
Reverse Transcriptase Polymerase Chain Reaction | 2 | 0.0 |
Gene Frequency | 6 | 0.0 |
Genotype | 9 | 0.0 |
Glutathione Peroxidase/*genetics/metabolism | 3 | 50.0 |
Polymorphism, Genetic | 7 | 0.0 |
Glutathione/metabolism | 4 | 1.0 |
Oligonucleotides, Antisense/pharmacology | 2 | 0.0 |
Tumor Cells, Cultured | 6 | 0.0 |
Aged | 5 | 0.0 |
*Genetic Predisposition to Disease | 2 | 0.0 |
Leucine/genetics | 2 | 3.0 |
Logistic Models | 2 | 0.0 |
Middle Aged | 8 | 0.0 |
Superoxide Dismutase/genetics | 2 | 2.0 |
Adult | 12 | 0.0 |
Selenium/blood | 2 | 18.0 |
Alleles | 7 | 0.0 |
Base Sequence | 8 | 0.0 |
*Polymorphism, Single Nucleotide | 3 | 0.0 |
Glutathione Peroxidase/*genetics/physiology | 2 | 100.0 |
Oxidative Stress | 4 | 1.0 |
Smoking/adverse effects | 2 | 0.0 |
Amino Acid Sequence | 4 | 0.0 |
Databases, Factual | 2 | 0.0 |
Molecular Sequence Data | 9 | 0.0 |
Molecular Weight | 2 | 0.0 |
Oxidative Stress/*genetics | 2 | 7.0 |
Aged, 80 and over | 2 | 0.0 |
Case-Control Studies | 2 | 0.0 |
Comparative Study | 4 | 0.0 |
Risk Factors | 2 | 0.0 |
Signal Transduction | 3 | 0.0 |
Sequence Analysis, DNA | 2 | 0.0 |
Hela Cells | 2 | 0.0 |
Protein Biosynthesis | 2 | 0.0 |
Glutathione Peroxidase/biosynthesis/*genetics | 2 | 66.0 |
Mice, Inbred CBA | 2 | 0.0 |
Mice, Transgenic | 2 | 0.0 |
Transcription, Genetic | 2 | 0.0 |
Cloning, Molecular | 3 | 0.0 |
Selenocysteine/*metabolism | 3 | 75.0 |
Apoptosis/drug effects/*physiology | 2 | 0.0 |
Caspases/metabolism | 3 | 0.0 |
Cell Line, Tumor | 2 | 0.0 |
Cytosol/enzymology | 2 | 1.0 |
Reactive Oxygen Species/metabolism | 4 | 1.0 |
Child | 2 | 0.0 |
Glutathione Peroxidase/*metabolism | 3 | 21.0 |
Hydrogen Peroxide/*pharmacology | 2 | 3.0 |
Nucleic Acid Conformation | 3 | 0.0 |
Chromosomes, Human, Pair 3 | 2 | 1.0 |
DNA Mutational Analysis | 2 | 0.0 |
DNA, Neoplasm/genetics | 2 | 0.0 |
Genes, Structural | 2 | 0.0 |
Sequence Deletion | 2 | 0.0 |
Lod Score | 2 | 0.0 |
Pedigree | 2 | 0.0 |
Polymorphism, Restriction Fragment Length | 2 | 0.0 |
Glutathione Peroxidase/genetics/*metabolism | 2 | 33.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 2 | 0.0 |
Cameroon | 2 | 9.0 |
Erythrocytes/enzymology | 2 | 0.0 |
Blotting, Southern | 2 | 0.0 |
Chromosome Mapping | 3 | 0.0 |
*Chromosomes, Human, Pair 3 | 2 | 0.0 |
Hamsters | 2 | 0.0 |
Sequence Homology, Nucleic Acid | 2 | 0.0 |
African Continental Ancestry Group | 2 | 0.0 |
*Alleles | 2 | 0.0 |
Congo | 2 | 40.0 |
Erythrocytes/*enzymology | 3 | 0.0 |
Glutathione Peroxidase/blood/*genetics | 3 | 100.0 |
DNA Fragmentation | 2 | 0.0 |
